Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00612235 · ClinicalTrials.gov registry record
Premenstrual Dysphoric Disorder and Antiepileptic Drugs
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 80
- Enrollment target
NCT00612235 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 80 participants.
The verdict
NCT00612235 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
This study is being done to determine if there are differences in mood during the menstrual cycle among women with epilepsy who take various different antiepileptic drugs and women without epilepsy.
Interventions
- OTHER No Intervention
- DRUG Lamotrigine
- DRUG Levetiracetam
- DRUG Carbamazepine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00612235
The ClinicalTrials.gov registry entry for NCT00612235 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which No Intervention is the first listed.
NCT00612235 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00612235 about?
NCT00612235 is a clinical study titled "Premenstrual Dysphoric Disorder and Antiepileptic Drugs". This study is being done to determine if there are differences in mood during the menstrual cycle among women with epilepsy who take various different antiepileptic drugs and women without epilepsy.
What is the current status of trial NCT00612235?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2008-04. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00612235?
The interventions under investigation include: No Intervention (OTHER), Lamotrigine (DRUG), Levetiracetam (DRUG), Carbamazepine (DRUG).
Who is sponsoring clinical trial NCT00612235?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.